1200005I advanced bioscience laboratories, INC.; manufacture and characterization services for vaccines & other biologics; to X20
Ended Awarded Last action
- Contract number
- HHSN27200020
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,812,395
Award facts
- Contract value 100% obligated
- $1,812,395.46 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $63,053 | |
| Supplemental Agreement for work within scope | $67,144 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $71,758 | |
| Supplemental Agreement for work within scope | -$71,758 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $96,456 | |
| Exercise an Option | $455,190 | |
| Exercise an Option | $730,336 | |
| Original award | $463,269 |
Show all 12
About this award
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for $1,812,395.46 and provides for the manufacture and characterization of vaccines and other biologics. The contract does not have a set-aside designation. ABL is a foreign-owned, for-profit organization that specializes in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The company has extensive experience supporting infectious disease research and product development initiatives for government agencies, academic institutions, and industry clients. This contract is part of ABL's work on various Indefinite Delivery Vehicles (IDVs) with NIAID, the National Institute of Neurological Disorders and Stroke (NINDS), and the National Cancer Institute (NCI), which demonstrate the company's broad capabilities in biopharmaceutical research and development across multiple disease areas.
Quick answers
Who was awarded contract HHSN27200020?
HHSN27200020 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 16, 2016.
How much is contract HHSN27200020 worth?
The government has obligated $1,812,395 on HHSN27200020.
Is contract HHSN27200020 an order under another contract?
Yes. HHSN27200020 is a delivery order under HHSN272201200005I, an indefinite delivery contract.
Was contract HHSN27200020 competed?
The extent of competition for HHSN27200020 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award